John Rossi

John Rossi

Company: CERo Therapeutics

Job title: Senior Vice President Research CERo Research, Head of Translational Medicine

Seminars:

Introducing Chimeric Engulfment Receptors CERs: Combining Classic CAR-T with Small Molecule Therapy to Improve Tumor Cell Clearance 11:30 am

Characterizing CER T cells to enhance inducible target specific cellular damage, uptake and display of tumor antigens for removal of diseased cells Discussing how this novel MOA may lead to a more durable response Presenting non-clinical MOA data and future directionsRead more

day: Day Two

Chair’s Opening Remarks 8:45 am

Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.